Price $113.59 |
Market Cap
14.77B
|
Sector Health Care |
Div. Growth
4.40%
|
|
P/E
20.1
|
P/B
2.55
|
P/S
1.97
|
Dividend %
2.00%
|
|
P/CF
21.3
|
P/FCF
28.6
|
Op. Cash Flow
1.25M
|
FCF
3.8
|
|
Op. Margin
15.10%
|
Net Margin
9.90%
|
ROE
13.20%
|
ROI
9.40%
|
|
ROA
6.00%
|
EPS Growth
4.60%
|
Current Ratio
1.3
|
Debt/Equity
70.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $2.94 | - | - | 70.1M | Strong Buy |
| Titan Pharmaceuticals, Inc. (TTNP) | $0.21 | - | - | 23M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.87 | - | - | 13.5M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $5.77 | - | - | 28.6M | Strong Buy |
| Tivity Health Inc (TVTY) | $13.85 | - | - | 783.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
